Study of timed aspirin use on daily body rhythms
This early-phase study tests whether taking aspirin at specific times changes your body’s daily rhythms (“chronobiome”). The results may help guide safer and more effective aspirin timing in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and generally healthy based on screening tests
- If you have high blood pressure, it must be well controlled (diastolic ≤100 at screening)
- Your body weight must be in a safe range for the study (BMI 18 to 30)
- You must not use tobacco (including nicotine replacement) for at least 3 months before screening
- If you can become pregnant, you must use reliable birth control and agree to regular pregnancy tests
- You must test negative for drugs and nicotine at screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies which aspirin dose works best in people with COPD, with the goal of improving disease control. You may be asked to take aspirin and be monitored for safety, especially bleeding risk and heart/brain history.
This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.
This trial studies whether taking your daily aspirin in the morning or at bedtime changes heart and circulation outcomes. It is meant to see if timing matters for people who already take aspirin every day.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This study compares whether a lower dose of aspirin (50 mg) works as well as a standard dose (100 mg) for older adults who have had heart attacks, strokes, or other heart and blood vessel problems. The goal is to find the safest effective dose to prevent future events.
This early-stage study tests how a daily aspirin tablet behaves in the body and how it affects blood/clotting markers in people with type 2 diabetes. It may help researchers understand whether this form of aspirin could be useful, especially if you’re not currently taking aspirin.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.